首页> 外文期刊>Scandinavian journal of gastroenterology. >Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
【24h】

Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.

机译:组胺2受体拮抗剂西咪替丁,雷尼替丁和法莫替丁对胃癌患者外周血单个核细胞免疫调节作用的比较。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Histamine-2 receptor antagonist (H2-RA) have been shown to improve the function of various parts of the immune system. The proposed mechanism of the immunomodulative effects of H2-RA has been considered to be the inhibition of suppressor T-lymphocyte activity, an increase in interleukin-2 production, and an enhancement of natural killer cell activity. Most of these studies were done with cimetidine. Comparative data with other H2-RA are limited and conflict on immunomodulative effects. Comparison of the actions of H2-RA on the immune system is required. METHODS: We compared the immunodulative effect of the H2-RAs cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells (PBMC) in normal controls and patients with gastric cancer. DNA synthesis, cytotoxicity against K562 cells, and the levels of soluble interleukin-2 receptor (sIL-2R) in supernatant were measured after addition of the various H2-RA to PBMC cultures. RESULTS: Subjects with gastric cancer showed significantlyhigher levels of suppressor lymphocyte activity than normal controls. These levels were restored to levels of normal controls by the addition of cimetidine. Statistically significant lymphoblastogenesis and cytotoxicity against K562 cells were observed only in cimetidine-treated PBMC (p < 0.05); such effects were not observed in ranitidine- or famotidine-treated PBMC. Significantly increased levels of sIL-2R were found in supernatants obtained from culture flasks treated with cimetidine and phytohemagglutinin or ranitidine and phytohemagglutinin (p < 0.01). CONCLUSIONS: Of the three H2-RAs tested, cimetidine had the strongest and famotidine the weakest immunomodulating effect. Only cimetidine augmented the cytotoxicity and proliferative response of lymphocyte to mitogen; neither ranitidine nor famotidine had such an effect. These results might be due to their structural differences. In addition, the immunologic effects of H2-RA are unlikely to be mediated via specific interaction at the H2 receptor.
机译:背景:组胺2受体拮抗剂(H2-RA)已被证明可以改善免疫系统各个部分的功能。 H2-RA的免疫调节作用的机制被认为是抑制抑制性T淋巴细胞的活性,增加白介素2的产生,并增强自然杀伤细胞的活性。这些研究大多数是用西咪替丁完成的。与其他H2-RA的比较数据有限,并且在免疫调节作用上存在冲突。需要比较H2-RA对免疫系统的作用。方法:我们比较了H2-RAs西咪替丁,雷尼替丁和法莫替丁对正常对照组和胃癌患者外周血单个核细胞(PBMC)的免疫抑制作用。在将各种H2-RA加入PBMC培养物中后,测量DNA合成,对K562细胞的细胞毒性以及上清液中可溶性白介素2受体(sIL-2R)的水平。结果:胃癌患者的抑制淋巴细胞活性水平明显高于正常对照组。通过添加西咪替丁,这些水平恢复到正常对照水平。仅在西咪替丁治疗的PBMC中观察到对K562细胞具有统计学意义的淋巴母细胞生成和细胞毒性(p <0.05);在雷尼替丁或法莫替丁处理的PBMC中未观察到此类作用。从用西咪替丁和植物血凝素或雷尼替丁和植物血凝素处理的培养瓶中获得的上清液中发现sIL-2R含量显着增加(p <0.01)。结论:在所测试的三个H2-RA中,西咪替丁的免疫调节作用最强,法莫替丁的免疫调节作用最弱。仅西咪替丁可增强淋巴细胞对有丝分裂原的细胞毒性和增殖反应。雷尼替丁和法莫替丁均无此作用。这些结果可能是由于它们的结构差异。另外,H2-RA的免疫学作用不可能通过H2受体的特异性相互作用来介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号